Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Pancoast tumor physical examination

Introduction

Overveiw

Overveiw

Common physical examination findings of Pancoast tumor include decreased/absent breath sounds, pallor, low-grade fever, and tachypnea. On physical examination, Pancoast tumor may present with features of lethargy, emaciation, confusion, low-grade fever, decreased sPO2, tachypnea, tachycardia, low blood pressure, decreased/absent breath sounds, bone pain, fractures (usually in the vertebrae, femur, pelvic bones, and the ribs), pallor, decreased sweating on ipsilateral side of the face, ptosis, miosis, anhydrosis, supraclavicular lymphadenopathy, cranial nerve palsies, tingling and pain along the distribution of ulnar nerve, clubbing of fingers, weakness of arms and hands, hemiplegia, paraplegia, shoulder pain, edematous swelling of the ipsilateral arm.

Physical Examination

Physical Examination

Pancoast tumor is a subtype of lung cancer localized to the apical portion of the lung. Common physical examination findings of Pancoast tumor include decreased/absent breath sounds, pallor, low-grade fever, and tachypnea. On Physical examination pancoast tumor may present with the features including: [1][2][3][4][5][6][7]

General appearance

Patients with Pancoast tumor generally appear lethargic, emaciated, and confused.

Vital Signs

Chest

Skeletal

Skin

HEENT

CNS

Extremities

References

References

  1. ↑ Degner, Lesley F.; Sloan, Jeffrey A. (1995). “Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer”. Journal of Pain and Symptom Management. 10 (6): 423–431. doi:10.1016/0885-3924(95)00056-5. ISSNΒ 0885-3924.
  2. ↑ Feinstein AR, Wells CK (1990). “A clinical-severity staging system for patients with lung cancer”. Medicine (Baltimore). 69 (1): 1–33. PMIDΒ 2299974.
  3. ↑ Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J (1985). “Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont”. Cancer. 56 (8): 2107–11. PMIDΒ 2992757.
  4. ↑ Hirshberg B, Biran I, Glazer M, Kramer MR (1997). “Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital”. Chest. 112 (2): 440–4. PMIDΒ 9266882.
  5. ↑ Kuo CW, Chen YM, Chao JY, Tsai CM, Perng RP (2000). “Non-small cell lung cancer in very young and very old patients”. Chest. 117 (2): 354–7. PMIDΒ 10669674.
  6. ↑ Lepper PM, Ott SR, Hoppe H, Schumann C, Stammberger U, Bugalho A, Frese S, SchmΓΌcking M, Blumstein NM, Diehm N, Bals R, Hamacher J (2011). “Superior vena cava syndrome in thoracic malignancies”. Respir Care. 56 (5): 653–66. doi:10.4187/respcare.00947. PMIDΒ 21276318.
  7. ↑ Buccheri, G. (2004). “Lung cancer: clinical presentation and specialist referral time”. European Respiratory Journal. 24 (6): 898–904. doi:10.1183/09031936.04.00113603. ISSNΒ 0903-1936.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]